<DOC>
	<DOC>NCT00548301</DOC>
	<brief_summary>The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.</brief_summary>
	<brief_title>Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Diagnosis of moderate to severe dry eye syndrome with or without Sjogren's syndrome or other autoimmune disease Intraocular or refractive surgery in the study eye within 3 months prior to study start Unwilling to discontinue use of contact lenses during the runin and duration of the study Pregnancy or lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>